Medical Disorders
Resources
Basic InformationLookupsLatest News
New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 ComplicationPlant-Based Diet Brings Better 'Microbiome,' Healthier LifeAnswering Your Qs on the New COVID VaccinesCommon Blood Pressure Meds Won't Up Risks for COVID Patients: StudyHealth Officials Work to Speed Up U.S. COVID Vaccine RolloutAllergists' Group Offers Guidelines on COVID-19 VaccinesFacebook Posts Big Drivers in Vaccine Resistance, Study FindsBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineBiden Says He Will Release All Vaccine Doses After Taking Office'Pandemic Fatigue' Setting in? Here's How to Stay Safe and StrongCould High Pollen Levels Trigger Pelvic Pain?Record Number of COVID Cases, Deaths Reported in U.S.COVID Survivors' Plasma Might Prevent Worsening Illness in Older Patients: StudyAHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Certain Antibiotics Linked With Upped Risk for Deadly Aortic AneurysmsDeath Risk Nearly Doubles When COVID Strikes People With Heart FailureMore Infectious COVID Variant Likely Widespread in the U.S., Experts SayRed Cross Issues Call for More Blood Plasma to Treat COVID PatientsPediatricians' Group Says School Is Priority, With Proper Safety MeasuresMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudyAllergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDCSurvey Shows Mental Woes Spiked in U.S. Pandemic's First MonthsYour 'To-Do' List as You Await a COVID VaccineSome Americans Can't Access Telemedicine, Study ShowsU.S. COVID Hospitalizations Reach Record High as California Hospitals Run Out of OxygenVaccine Rollout Could Have Americans Back to Normalcy by Summer, Expert SaysCould Umbilical Cord Stem Cells Be a Lifesaver Against Severe COVID-19?Kids With Congenital Heart Disease Face Higher Odds of Mental Health Issues
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Research Reveals Why COVID Pneumonia Is More Deadly

HealthDay News
by Robert Preidt
Updated: Jan 12th 2021

new article illustration

TUESDAY, Jan. 12, 2021 (HealthDay News) -- Unlike regular pneumonia, COVID-19 pneumonia spreads like many "wildfires" throughout the lungs, researchers say.

This may explain why COVID-19 pneumonia lasts longer and causes more harm than typical pneumonia, according to the researchers at Northwestern Medicine in Chicago.

The research team said that their aim is to make COVID-19 more like a bad cold.

For the study, the team analyzed immune cells from the lungs of COVID-19 pneumonia patients and compared them to cells from patients with pneumonia caused by other viruses or bacteria.

While other types of pneumonia rapidly infect large regions of the lungs, COVID-19 begins in numerous small areas of the lungs. It then uses the lungs' own immune cells to spread across the lungs over many days or even weeks. This is similar to how multiple wildfires spread through a forest, the study authors explained.

As COVID-19 pneumonia slowly moves through the lungs, it leaves damaged lung tissue in its wake and contributes to the fever, low blood pressure and organ damage common in COVID-19 patients, the team said.

The long duration of COVID-19 pneumonia, rather than greater severity, may be why it causes more serious complications than other types of pneumonia, according to the study authors. The report was published online Jan. 11 in the journal Nature.

The researchers also identified immune cells -- macrophages and T cells -- that could be important targets when treating severe COVID-19 pneumonia. Macrophages typically protect the lungs, but can be infected by the new coronavirus and help spread the infection through the lungs, the team noted in a Northwestern news release.

In a clinical trial early this year, the investigators plan to test an experimental drug that targets these immune cells in COVID-19 pneumonia patients. The drug reduces the inflammatory response of these immune cells.

"Our goal is to make COVID-19 mild instead of severe, making it comparable to a bad cold," study co-author Dr. Scott Budinger said in the news release. He is chief of pulmonary and critical care medicine at Northwestern University Feinberg School of Medicine.

Study co-author Dr. Richard Wunderink, professor of pulmonary and critical care medicine at Feinberg and medical director of Northwestern Medicine's ICU, added that "this effort truly represents a 'moonshot' in COVID-19 research."

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.

SOURCE: Northwestern Medicine, news release, Jan. 11, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net